Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection.

Hübner MP, Killoran KE, Rajnik M, Wilson S, Yim KC, Torrero MN, Morris CP, Nikonenko B, Blanco JC, Hemming VG, Mitre E.

PLoS Negl Trop Dis. 2012;6(12):e1970. doi: 10.1371/journal.pntd.0001970. Epub 2012 Dec 20.

3.

Pediatric medical education in the United States military.

Pierce JR, Hemming VG, Ottolini MG, Lopreiato JO, Yu CE.

Pediatrics. 2012 Feb;129 Suppl 1:S11-9. doi: 10.1542/peds.2010-3797d. No abstract available.

PMID:
22300824
4.

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.

Groothuis JR, Hoopes JM, Hemming VG.

Adv Ther. 2011 Feb;28(2):110-25. doi: 10.1007/s12325-010-0101-y. Epub 2011 Feb 4. Review.

PMID:
21318605
5.

Characterization of late tuberculosis infection in Sigmodon hispidus.

Elwood RL, Rajnik M, Wilson S, Yim K, Blanco JC, Nikonenko B, Hemming VG.

Tuberculosis (Edinb). 2009 Mar;89(2):183-8. doi: 10.1016/j.tube.2009.01.003. Epub 2009 Feb 15.

PMID:
19223233
6.

Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children.

Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Sztein MB, Boukhvalova MS, Hemming VG, Blanco JC, Vogel SN.

J Immunol. 2007 Sep 1;179(5):3171-7.

7.

The American cotton rat: a novel model for pulmonary tuberculosis.

Elwood RL, Wilson S, Blanco JC, Yim K, Pletneva L, Nikonenko B, Samala R, Joshi S, Hemming VG, Trucksis M.

Tuberculosis (Edinb). 2007 Mar;87(2):145-54. Epub 2006 Sep 12.

PMID:
16973421
8.

Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling.

Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Blanco JC, Segal DM, Vogel SN.

J Immunol. 2006 Jul 1;177(1):322-32.

9.

Comparison of corticosteroids for treatment of respiratory syncytial virus bronchiolitis and pneumonia in cotton rats.

Ottolini MG, Curtis SJ, Porter DD, Mathews A, Richardson JY, Hemming VG, Prince GA.

Antimicrob Agents Chemother. 2002 Jul;46(7):2299-302.

10.

Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.

Hemming VG.

Clin Diagn Lab Immunol. 2001 Sep;8(5):859-63. Review. No abstract available.

11.
12.

Physicians' perceptions of the status of adolescent health care within the military health system.

Griffith JR, Schwab KA, Robinson A, Hemming VG.

Mil Med. 1999 Oct;164(10):683-7.

PMID:
10544619
13.

Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model.

Ottolini MG, Porter DD, Hemming VG, Zimmerman MN, Schwab NM, Prince GA.

Bone Marrow Transplant. 1999 Jul;24(1):41-5.

14.

Human respiratory syncytial virus produces prolonged alterations of neural control in airways of developing ferrets.

Colasurdo GN, Hemming VG, Prince GA, Gelfand AS, Loader JE, Larsen GL.

Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1506-11.

PMID:
9603130
15.

Sustaining membership lecture award. Dogma, the shade that blinds.

Hemming VG.

Mil Med. 1998 Apr;163(4):265-8.

PMID:
9575775
17.

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang SC, Dormitzer M, O'Grady J, Koenig S, Tamura JK, Woods R, Bansal G, Couchenour D, Tsao E, Hall WC, Young JF.

J Infect Dis. 1997 Nov;176(5):1215-24.

PMID:
9359721
18.

Immunoprophylaxis of group B respiratory syncytial virus infection in cotton rats.

Faverio LA, Piazza FM, Johnson SA, Darnell ME, Ottolini MG, Hemming VG, Prince GA.

J Infect Dis. 1997 Apr;175(4):932-4.

PMID:
9086152
19.

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA.

Pediatrics. 1997 Mar;99(3):454-61.

PMID:
9041304
20.

Semi-permissive replication and functional aspects of the immune response in a cotton rat model of human parainfluenza virus type 3 infection.

Ottolini MG, Porter DD, Hemming VG, Hensen SA, Sami IR, Prince GA.

J Gen Virol. 1996 Aug;77 ( Pt 8):1739-43.

PMID:
8760420
21.

Topical immunoglobulin is an effective therapy for parainfluenza type 3 in a cotton rat model.

Ottolini MG, Hemming VG, Piazza FM, Johnson SA, Darnell ME, Prince GA.

J Infect Dis. 1995 Jul;172(1):243-5.

PMID:
7797921
22.

Human respiratory syncytial virus affects nonadrenergic noncholinergic inhibition in cotton rat airways.

Colasurdo GN, Hemming VG, Prince GA, Loader JE, Graves JP, Larsen GL.

Am J Physiol. 1995 Jun;268(6 Pt 1):L1006-11.

PMID:
7611422
24.

Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.

Groothuis JR, Simoes EA, Lehr MV, Kramer AA, Hemming VG, Rodriguez WJ, Arrobio J, Welliver RC, Siber GR.

Antimicrob Agents Chemother. 1995 Mar;39(3):668-71.

25.

Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats.

Sami IR, Piazza FM, Johnson SA, Darnell ME, Ottolini MG, Hemming VG, Prince GA.

J Infect Dis. 1995 Feb;171(2):440-3.

PMID:
7844385
26.

Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Hemming VG, Prince GA, Groothuis JR, Siber GR.

Clin Microbiol Rev. 1995 Jan;8(1):22-33. Review.

27.

Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates.

Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS, Subramanian KN, Hankins CT, Cruess DF, Hemming VG, et al.

J Pediatr. 1994 Dec;125(6 Pt 1):922-30.

PMID:
7996367
28.

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin.

Siber GR, Leombruno D, Leszczynski J, McIver J, Bodkin D, Gonin R, Thompson CM, Walsh EE, Piedra PA, Hemming VG, et al.

J Infect Dis. 1994 Jun;169(6):1368-73.

PMID:
8195619
29.
30.

Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin.

Fischer GW, Cieslak TJ, Wilson SR, Weisman LE, Hemming VG.

J Infect Dis. 1994 Feb;169(2):324-9.

PMID:
8106765
31.

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.

Meissner HC, Fulton DR, Groothuis JR, Geggel RL, Marx GR, Hemming VG, Hougen T, Snydman DR.

Antimicrob Agents Chemother. 1993 Aug;37(8):1655-8.

32.

Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.

Weisman LE, Anthony BF, Hemming VG, Fischer GW.

J Pediatr. 1993 Jun;122(6):929-37.

PMID:
8501574
33.

Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection.

Piazza FM, Johnson SA, Darnell ME, Porter DD, Hemming VG, Prince GA.

J Virol. 1993 Mar;67(3):1503-10.

34.

Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol.

Piazza FM, Johnson SA, Ottolini MG, Schmidt HJ, Darnell ME, Hemming VG, Prince GA.

J Infect Dis. 1992 Dec;166(6):1422-4. Erratum in: J Infect Dis 1994 Feb;169(2):482.

PMID:
1431258
35.

Early-onset group B streptococcal sepsis: a current assessment.

Weisman LE, Stoll BJ, Cruess DF, Hall RT, Merenstein GB, Hemming VG, Fischer GW.

J Pediatr. 1992 Sep;121(3):428-33.

PMID:
1517922
36.

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay.

Siber GR, Leszcynski J, Pena-Cruz V, Ferren-Gardner C, Anderson R, Hemming VG, Walsh EE, Burns J, McIntosh K, Gonin R, et al.

J Infect Dis. 1992 Mar;165(3):456-63.

PMID:
1538152
37.

Respiratory syncytial virus: babies and antibodies.

Hemming VG, Prince GA.

Infect Agents Dis. 1992 Feb;1(1):24-32. Review. No abstract available.

PMID:
1365525
38.

Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review.

Fischer GW, Weisman LE, Hemming VG.

Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S92-7.

PMID:
1728993
39.

Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.

Muelenaer PM, Henderson FW, Hemming VG, Walsh EE, Anderson LJ, Prince GA, Murphy BR.

J Infect Dis. 1991 Jul;164(1):15-21.

PMID:
2056202
40.

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group.

Groothuis JR, Levin MJ, Rodriguez W, Hall CB, Long CE, Kim HW, Lauer BA, Hemming VG.

Antimicrob Agents Chemother. 1991 Jul;35(7):1469-73.

42.

Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats.

Prince GA, Hemming VG, Horswood RL, Baron PA, Murphy BR, Chanock RM.

J Virol. 1990 Jun;64(6):3091-2.

43.

Polyvalent group B streptococcal immune globulin for intravenous administration: overview.

Fischer GW, Hemming VG, Gloser HP, Bachmayer H, von Pilar CE, Wilson SR, Baron PA.

Rev Infect Dis. 1990 May-Jun;12 Suppl 4:S483-9; discussion S489-91.

PMID:
2194273
44.

Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis.

Hemming VG, Prince GA.

Rev Infect Dis. 1990 May-Jun;12 Suppl 4:S470-4; discussion S474-5. Review.

PMID:
2194271
45.

A survey of infants with neonatal sepsis in U.S. Army hospitals.

Horton JA, Hemming VG, Cruess DF, Korper M, Capper LM.

Mil Med. 1989 Nov;154(11):564-7.

PMID:
2511512
46.

Pharmacokinetics of intravenous immunoglobulin in neonates.

Weisman LE, Fischer GW, Marinelli P, Hemming VG, Pierce JR, Golden SM, Peck CC.

Vox Sang. 1989;57(4):243-8.

PMID:
2694604
47.

Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys.

Hemming VG, Prince GA, London WT, Baron PA, Brown R, Chanock RM.

Antimicrob Agents Chemother. 1988 Aug;32(8):1269-70.

48.

Respiratory syncytial virus infections and intravenous gamma-globulins.

Hemming VG, Prince GA, Rodriguez W, Kim HW, Brandt CD, Parrott RH, London WT, Fischer GW, Baron PA, Henson SA.

Pediatr Infect Dis J. 1988 May;7(5 Suppl):S103-6. Review.

PMID:
3041354
49.

Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.

Hendry RM, Burns JC, Walsh EE, Graham BS, Wright PF, Hemming VG, Rodriguez WJ, Kim HW, Prince GA, McIntosh K, et al.

J Infect Dis. 1988 Apr;157(4):640-7.

PMID:
3346563
50.

Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.

Hemming VG, Rodriguez W, Kim HW, Brandt CD, Parrott RH, Burch B, Prince GA, Baron PA, Fink RJ, Reaman G.

Antimicrob Agents Chemother. 1987 Dec;31(12):1882-6.

Supplemental Content

Loading ...
Support Center